Praxis will receive an upfront payment from UCB, and if the option is exercised by UCB, would be eligible to receive an option fee and future success-based development and commercialization milestone payments, for a total of up to ~$100M, in addition to tiered royalties on net sales of any resulting products from the collaboration.
Stock up 2.3% after-hours.
This text was written byObserveI am a seasoned monetary analyst with a ardour for puzzling out the complexities of the...
Pension Fund Regulatory And Improvement Authority Chairman S Ramann | Picture Credit score: EOS5D4 Pension Fund Regulatory And Improvement Authority...
The Supreme Courtroom on Friday held that spectrum can't be handled as a company asset able to being restructured...
BSE has obtained approval from capital markets regulator Sebi to launch by-product contracts on the "BSE Targeted Midcap Index," increasing...
This text was written byObserveI'm an skilled Danger Administration Enterprise Analyst at a Systemic Greek Financial institution, with a powerful...
“AI listened to 2 Cr calls, transformed voice to textual content, and gave us information. Textual content-to-data conversion occurred for...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
